MedPath

BAYLOR COLLEGE OF MEDICINE

BAYLOR COLLEGE OF MEDICINE logo
🇺🇸United States
Ownership
Private
Established
1900-10-30
Employees
10K
Market Cap
-
Website
http://www.bcm.edu

Clinical Trials

722

Active:61
Completed:383

Trial Phases

6 Phases

Early Phase 1:17
Phase 1:181
Phase 2:73
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (603 trials with phase data)• Click on a phase to view related trials

Not Applicable
259 (43.0%)
Phase 1
181 (30.0%)
Phase 2
73 (12.1%)
Phase 4
53 (8.8%)
Phase 3
20 (3.3%)
Early Phase 1
17 (2.8%)

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

Not Applicable
Not yet recruiting
Conditions
Obsessive Compulsive Disorder (OCD)
Anxiety Disorder of Childhood or Adolescence
Social Anxiety Disorder of Childhood
Generalized Anxiety Disorder (GAD)
Separation Anxiety Disorder
Panic Disorder
Panic Attacks
Panic Disorder (With or Without Agoraphobia)
Phobia, Specific
First Posted Date
2025-06-17
Last Posted Date
2025-06-17
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
174
Registration Number
NCT07024758
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia

Phase 4
Not yet recruiting
Conditions
Central Centrifugal Cicatricial Alopecia
Interventions
Biological: Platelet-Rich Plasma (PRP) Injections
Drug: Saline
First Posted Date
2025-05-31
Last Posted Date
2025-05-31
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
56
Registration Number
NCT06998433
Locations
🇺🇸

Jamail Specialty Care Center, Houston, Texas, United States

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Not Applicable
Recruiting
Conditions
Obesity and Diabetes Mellitus, Type 2
Diabetes Prevention
First Posted Date
2025-05-07
Last Posted Date
2025-06-17
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
30
Registration Number
NCT06959901
Locations
🇺🇸

Children's Nutrition Research Center, Houston, Texas, United States

Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke

Phase 1
Not yet recruiting
Conditions
Acute Ischemic Stroke
Interventions
First Posted Date
2025-05-04
Last Posted Date
2025-05-14
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
30
Registration Number
NCT06956521

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Not Applicable
Recruiting
Conditions
Obesity and Type 2 Diabetes
First Posted Date
2025-04-24
Last Posted Date
2025-04-25
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
40
Registration Number
NCT06943001
Locations
🇺🇸

USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 145
  • Next

News

Breakthrough mRNA Vaccine Shows Promise Against Deadly Elephant Virus in First Real-World Test

Two young Asian elephants at Cincinnati Zoo successfully overcame Elephant Endotheliotropic Herpesvirus (EEHV) infection after receiving an experimental mRNA vaccine developed by Houston Zoo and Baylor College of Medicine.

ERA 2025 to Feature Pivotal Nephrology Trials Including CONFIDENCE, ACHIEVE, and VISIONARY Studies

The 62nd European Renal Association Congress in Vienna will present seven late-breaking clinical trials addressing chronic kidney disease, dialysis patients, and glomerular disease developments.

U.S. Measles Outbreak Intensifies: 600+ Cases Reported as HHS Secretary's Stance on Vaccines Draws Criticism

A severe measles outbreak has spread to 21 states with over 600 confirmed cases in 2025, primarily affecting unvaccinated individuals, with experts suspecting significant underreporting of actual case numbers.

Election-Related Stress Reaches Critical Levels Among Americans, APA Survey Reveals

A new American Psychological Association poll reveals 77% of Americans report stress about the nation's future, with 69% specifically worried about the upcoming presidential election.

FDA Launches Landmark Clinical Trial to Assess Kratom's Addiction Potential

Baylor College of Medicine researchers are initiating a $5.5 million FDA-funded clinical trial to evaluate kratom's abuse potential compared to oxycodone, with results expected in three years.

PanCAN Study Completes Enrollment of 8,800 Participants to Investigate Diabetes-Pancreatic Cancer Link

PanCAN's Early Detection Initiative has successfully enrolled over 8,800 participants to study the relationship between new-onset diabetes and early pancreatic cancer detection.

Groundbreaking CAR T-Cell Trial at Ben Taub Hospital Shows Promise in Multiple Myeloma Treatment

Harris Health's Ben Taub Hospital launches innovative cellular immunotherapy trial for multiple myeloma patients, demonstrating remarkable results with a single T-cell injection treatment.

Groundbreaking 18-Year Remission Achieved in Neuroblastoma Patient Following CAR T-Cell Therapy

A phase 1 clinical trial of GD2-targeted CAR T-cell therapy has achieved the longest reported remission in neuroblastoma treatment, with one patient remaining cancer-free for over 18 years.

Study Shows DAA Therapy Matches Interferon in Reducing Liver Cancer Risk for HCV Patients

• A large VA healthcare system study reveals that direct-acting antiviral (DAA) therapy significantly reduces hepatocellular carcinoma risk compared to no treatment in HCV patients with cirrhosis. • The research demonstrates comparable hepatocellular carcinoma risk reduction between DAA therapy and historical interferon treatments, with DAA achieving superior cure rates of over 95%. • Among study participants, 89.39% of DAA-treated patients achieved sustained virologic response, compared to 36.55% in the interferon-treated group, supporting DAA's favorable risk-benefit profile.

Precision Medicine and Value-Based Cancer Care: Navigating Implementation Challenges in Academic and Community Settings

Precision medicine adoption in oncology faces distinct challenges in academic and community settings, with issues ranging from workflow variations to bureaucratic constraints in implementing biomarker testing.

© Copyright 2025. All Rights Reserved by MedPath